BioStock: Cyxone's new management in place for the next phase
During the first half of 2020, Malmö based company Cyxone has strengthened its management team with a new COO and a new CEO. Through existing and new collaborations, the company has also begun to explore expanded and new indication areas, while also focusing on pushing the clinical development programs towards the next phase. The market’s appreciation of the company’s work has rewarded the share with an almost 50 percent share price increase during the first six months of the year.
Read the full article about Cyxone at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/